MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2024-12-31.

Income Overview

Net Income
-$5,887,830
EPS
-$0.14
Unit: Dollar

Income Statement
2024-12-31
Research and development-Nonrelated Party
1,840,081
Research and development-Related Party
58,000
General and administrative
1,942,163
Total operating expenses
3,840,244
Loss from operations
-3,840,244
Interest expense-Nonrelated Party
126,476
Interest expense-Related Party
651,910
Interest expense - amortization of debt discount-Nonrelated Party
156,221
Interest expense - amortization of debt discount-Related Party
153,693
Change in fair value of derivative liabilities-Nonrelated Party
353,174
Change in fair value of derivative liabilities-Related Party
44,835
Gain on extinguishment of note payable
17,893
Total other expense
-672,398
Net loss
-4,512,642
Dividend attributable to series a, b, and c preferred stockholders
1,375,188
Net loss applicable to common stockholders
-5,887,830
Basic EPS
-0.14
Diluted EPS
-0.14
Basic Average Shares
41,870,597
Diluted Average Shares
41,870,597
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss applicableto common...-$5,887,830 Net loss-$4,512,642 Dividend attributable toseries a, b, and c...$1,375,188 Loss from operations-$3,840,244 Total other expense-$672,398 Change in fair value ofderivative...$353,174 Change in fair value ofderivative...$44,835 Gain onextinguishment of note payable$17,893 Total operatingexpenses$3,840,244 Interestexpense-Related Party$651,910 Interest expense -amortization of debt...$156,221 Interest expense -amortization of debt...$153,693 Interestexpense-Nonrelated Party$126,476 General andadministrative$1,942,163 Research anddevelopment-Nonrelated Party$1,840,081 Research anddevelopment-Related Party$58,000

Cell Source, Inc. (CLCS)

Cell Source, Inc. (CLCS)